The Impact of Non-Alcoholic Fatty Pancreas Disease on Outcome of Acute Pancreatitis
1 other identifier
observational
1,662
1 country
1
Brief Summary
Obesity is a well-established risk factor for acute pancreatitis (AP). As for non-alcoholic fatty pancreas disease (NAFPD), it is evident that it is correlated with obesity. This is apparently the first study evaluating the association between NAFPD and severity of AP after taking into account several covariates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 6, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 3, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2017
CompletedFirst Submitted
Initial submission to the registry
January 3, 2018
CompletedFirst Posted
Study publicly available on registry
January 9, 2018
CompletedJanuary 9, 2018
January 1, 2018
27 days
January 3, 2018
January 3, 2018
Conditions
Outcome Measures
Primary Outcomes (3)
Comparison of characteristics and variables according to severity of AP.
Comparison of characteristics and variables according to severity of AP by One-Way Analysis of variance(ANOVA) and Pearson chi-square test.
the physical examination data in the year of 2017
The association between pancreas attenuation and ICU transfer, pancreatitis severity, systemic and local complications and prognostic scores (APACHE II scores, Ranson score, BISAP score and SIRS).
The association between pancreas attenuation and ICU transfer, pancreatitis severity, systemic and local complications and prognostic scores (APACHE II scores, Ranson score, BISAP score and SIRS) by Likelihood Ratio test.
the physical examination data in the year of 2017
BMI adjusted hazard ratios (HRs) and 95% CIs for the relationship between NAFPD and mortality of acute pancreatitis, evaluated by pancreas attenuation (HU), P/S ratio.
BMI adjusted hazard ratios (HRs) and 95% CIs for the relationship between NAFPD and mortality of acute pancreatitis, evaluated by pancreas attenuation (HU), P/S ratio by cox proportional hazards models.
the physical examination data in the year of 2017
Eligibility Criteria
Diagnosis criteria for AP were the presence of at least 2 of the 3 following factors: (1) abdominal pain characteristic of AP, (2) serum amylase and/or lipase levels\>= 3 times the upper limit of normal, and (3) characteristic findings of AP on a CT scan
You may qualify if:
- diagnosed with AP
- age\>18y
You may not qualify if:
- age\<18y
- missing data in the electronic medical record
- prior attacks of AP
- without spleen
- with ambiguous pancreatic margin
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ningbo NO.1 hospital
Ningbo, Zhejiang, 315010, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lei Xu, Dr
Department of gastroenterology,Ningbo No.1 Hospital, Ningbo, China
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 3, 2018
First Posted
January 9, 2018
Study Start
November 6, 2017
Primary Completion
December 3, 2017
Study Completion
December 15, 2017
Last Updated
January 9, 2018
Record last verified: 2018-01